Formed by leading critical care specialists in March 2020, at the beginning of the Coronavirus pandemic, the ‘Front Line COVID-19 Critical Care Alliance’ is now a 501(c)(3) non-profit organization dedicated to developing highly effective treatment protocols to prevent the transmission of COVID-19 and to improve the outcomes for patients ill with the disease. They are of the opinion it could be a complementary bridge until the vaccine is widely available. Pulmonary and critical care specialist Pierre Kory says, “it is certainly another tool in the toolkit and we need everything we can to go after this pandemic”. More about it and links included.
MedPage article on 6 January 2021
Marik said in an article on 6 January 2021 that the group adapted the protocol for COVID-19, using a more potent steroid and adding an anticoagulant, along with other elements. The new name was MATH+, for methylprednisolone, ascorbic acid, thiamine, and heparin, plus a statin, zinc, vitamin D, famotidine, melatonin, and magnesium.
They maintain that ivermectin has a special combination of anti-viral and anti-inflammatory properties that make it useful preventively and for treating early and late-stage illness. Too good to be true? Not in the mind of FLCCC co-leader Paul Marik, MD, chief of pulmonary and critical care medicine at Eastern Virginia Medical School in Norfolk, who co-authored the review and meta-analysis based mainly on studies from outside the U.S.
“People are dying,” Marik said during a phone interview. “We treat patients at the bedside. We don’t have the ivory tower syndrome where you tell people what to do though you have no idea what you’re doing.” Group members, who are mostly critical care physicians, don’t see a need for more data and argue it would be unethical to give placebo to patients given the established safety of ivermectin. But that’s raising more than a few eyebrows among others in the field.
Dr. Andrews Hill’s Ivermectin meta-analysis, from University of Liverpool, England, supported by The Access to COVID-19 Tools (ACT) Accelerator. Presentation from MedinCell Workshop (16 December).
One Page Summary of the Clinical Trials Evidence for Ivermectin in COVID-19
In the past 4 months, numerous, controlled clinical trials from multiple centers and countries worldwide are reporting consistent, large improvements in COVID-19 patient outcomes when treated with ivermectin.
Number of Studies and Patients Among the Existing Clinical Trials of Ivermectin in COVID-19
• 27 controlled trials, including a total of 6,612 patients have been completed using well-matched control groups.
• 16 trials, including over 2,500 patients, are prospective, randomized, controlled studies.
• 11 of the 27 trials have been published in peer-reviewed journals, 3,900 patients, remainder are in pre-print.
READ MORE HERE:
News about FLCCC
Kory is the president of the Front-Line Covid-19 Critical Care Alliance (FLCCC) which is a group of critical care specialists.
They publish academic authors dedicated to developing effective treatment protocols to prevent the transmission of the virus. Kory made statements on 22 January 2021 that he knew the Ivermectin can help people, it shows quicker time to viral clearance, lower viral loads, faster times to recovery and lowered mortality rates and prevent transmission of the virus. Enough supplies be needed and governments need to put this into policy to treat those who are sick.
Kory says the FLCCC was not the first group to research the use of the drug against Covid-19, it is rather the first group to bring it to the world’s attention that it has been used by humans in different countries for riverblindness, but also for scabies and other diseases.
How does Ivermectin work?
According to the FLCCC, existing data shows that there are 10 main properties of the drug that proves it works.
1. Over the past decade, multiple studies have demonstrated that Ivermectin prevents the replication of many viruses, including influenza and Zika. The drug also prevents the replication of Covid-19, leading to absence of nearly all viral material within two days.
2. Ivermectin has anti-inflammatory properties. Several studies have shown that a common feature for patients that get severe Covid-19 is caused by an overly vigorous immune response and a hyper-inflammatory response.
3. Ivermectin has been shown to decrease viral load and protect against organ damage in multiple animal models when infected with similar coronaviruses.
4. Ivermectin prevents transmission whether taken either pre- or post-exposure.
5. It hastens recovery and prevents deterioration in patients with mild to moderate symptoms, 88% of the patients made a full recovery and experienced none of the symptoms after two doses.
6. It has been shown to reduce the number of ICU admissions and deaths in hospitalised patients.
7. Ivermectin reduces mortality in critically ill patients with Covid-19.
8. Ivermectin leads to reductions in case-fatality rates in regions with widespread use.
9. It has been shown to be a safe and affordable drug with minimal side effects for over 40 years of use and billions of doses administered.
10. The WHO has long included Ivermectin on its “List of essential medicines”.
FROM SOUTH AFRICA
A general practitioner from Durban, Dr Naseeba Kathrada who headed up a petition urging President Cyril Ramaphosa to set up an urgent special council to conduct a rapid review of the drug, says the pandemic has brought to light the holes in the country’s health-care system. She added that Sahpra has a set of rules, but they want the doctors to apply for a section 21 for every patient. That’s why she wrote the letter to the president, because filling out the forms is a long process and doctors need to tend to their patients.
In a series of tweets, Minister of Health Zweli Mkhize said that as it stands Ivermectin is not registered for human use in the country and remains to be registered for use in animals. It was the case yes and farmers are still using this products for decades.
And there are products humans are using for scabies and riverblindness, like other countries in Africa and South Africa – millions of African people are using ivermectin without problems.
More information ….
Ivermectin – Stromectol – Mectizan – Ivomec
Ivermectin – Dr Odendaal
Ivermectin – TLU – ProAgri
COVID-19: The Ivermectin African Enigma
Ivermectin – Nigeria
Ivermectin SA – Doctors and Afriforum